Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endoscopic submucosal steroid injection plus dilation for esophageal stricture after ESD
ChiCTR2600124399Phase 4Recruiting
- Sponsor
- Yancheng First People's Hospital
- Start
- May 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of prednisone in esophageal cancer and Esophageal stricture (2 arms), sponsored by Yancheng First People's Hospital. Primary endpoint: Endoscopic esophageal stricture. Started May 2026; status: recruiting.
02
Drugs
prednisone
03
Conditions
esophageal cancerEsophageal stricture
Beyond the preview
Go deeper on ChiCTR2600124399.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600124399.